199 related articles for article (PubMed ID: 10087069)
1. Apparent loss and hypertrophy of interneurons in a mouse model of neuronal ceroid lipofuscinosis: evidence for partial response to insulin-like growth factor-1 treatment.
Cooper JD; Messer A; Feng AK; Chua-Couzens J; Mobley WC
J Neurosci; 1999 Apr; 19(7):2556-67. PubMed ID: 10087069
[TBL] [Abstract][Full Text] [Related]
2. Neuronal ceroid lipofuscinosis (nclf), a new disorder of the mouse linked to chromosome 9.
Bronson RT; Donahue LR; Johnson KR; Tanner A; Lane PW; Faust JR
Am J Med Genet; 1998 May; 77(4):289-97. PubMed ID: 9600738
[TBL] [Abstract][Full Text] [Related]
3. A metabolomic comparison of mouse models of the Neuronal Ceroid Lipofuscinoses.
Salek RM; Pears MR; Cooper JD; Mitchison HM; Pearce DA; Mortishire-Smith RJ; Griffin JL
J Biomol NMR; 2011 Apr; 49(3-4):175-84. PubMed ID: 21461951
[TBL] [Abstract][Full Text] [Related]
4. Progression of early postnatal retinal pathology in a mouse model of neuronal ceroid lipofuscinosis.
Seigel GM; Wagner J; Wronska A; Campbell L; Ju W; Zhong N
Eye (Lond); 2005 Dec; 19(12):1306-12. PubMed ID: 15565184
[TBL] [Abstract][Full Text] [Related]
5. Late onset neurodegeneration in the Cln3-/- mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation.
Pontikis CC; Cella CV; Parihar N; Lim MJ; Chakrabarti S; Mitchison HM; Mobley WC; Rezaie P; Pearce DA; Cooper JD
Brain Res; 2004 Oct; 1023(2):231-42. PubMed ID: 15374749
[TBL] [Abstract][Full Text] [Related]
6. Different early ER-stress responses in the CLN8(mnd) mouse model of neuronal ceroid lipofuscinosis.
Galizzi G; Russo D; Deidda I; Cascio C; Passantino R; Guarneri R; Bigini P; Mennini T; Drago G; Guarneri P
Neurosci Lett; 2011 Jan; 488(3):258-62. PubMed ID: 21094208
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of the adenosine triphosphate synthase subunit C in the mnd mutant mouse. A model for neuronal ceroid lipofuscinosis.
Pardo CA; Rabin BA; Palmer DN; Price DL
Am J Pathol; 1994 Apr; 144(4):829-35. PubMed ID: 8160780
[TBL] [Abstract][Full Text] [Related]
8. The development of behavioral abnormalities in the motor neuron degeneration (mnd) mouse.
Bolivar VJ; Scott Ganus J; Messer A
Brain Res; 2002 May; 937(1-2):74-82. PubMed ID: 12020865
[TBL] [Abstract][Full Text] [Related]
9. Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis.
Kielar C; Maddox L; Bible E; Pontikis CC; Macauley SL; Griffey MA; Wong M; Sands MS; Cooper JD
Neurobiol Dis; 2007 Jan; 25(1):150-62. PubMed ID: 17046272
[TBL] [Abstract][Full Text] [Related]
10. Evidence that lysosomal storage of proteolipids is a cell autonomous process in the motor neuron degeneration (mnd) mouse, a model of neuronal ceroid lipofuscinosis.
Lipman RD; Donohue LR; Hoppe P; Bronson RT
Neurosci Lett; 1996 Nov; 219(2):111-4. PubMed ID: 8971792
[TBL] [Abstract][Full Text] [Related]
11. Dietary carnitine supplements slow disease progression in a putative mouse model for hereditary ceroid-lipofuscinosis.
Katz ML; Rice LM; Gao CL
J Neurosci Res; 1997 Oct; 50(1):123-32. PubMed ID: 9379488
[TBL] [Abstract][Full Text] [Related]
12. A murine model of variant late infantile ceroid lipofuscinosis recapitulates behavioral and pathological phenotypes of human disease.
Morgan JP; Magee H; Wong A; Nelson T; Koch B; Cooper JD; Weimer JM
PLoS One; 2013; 8(11):e78694. PubMed ID: 24223841
[TBL] [Abstract][Full Text] [Related]
13. An early-onset congenic strain of the motor neuron degeneration (mnd) mouse.
Messer A; Manley K; Plummer JA
Mol Genet Metab; 1999 Apr; 66(4):393-7. PubMed ID: 10191135
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal enzyme replacement therapy improves motor function and survival in a preclinical mouse model of infantile neuronal ceroid lipofuscinosis.
Lu JY; Nelvagal HR; Wang L; Birnbaum SG; Cooper JD; Hofmann SL
Mol Genet Metab; 2015; 116(1-2):98-105. PubMed ID: 25982063
[TBL] [Abstract][Full Text] [Related]
15. Retinal oxidation, apoptosis and age- and sex-differences in the mnd mutant mouse, a model of neuronal ceroid lipofuscinosis.
Guarneri R; Russo D; Cascio C; D'Agostino S; Galizzi G; Bigini P; Mennini T; Guarneri P
Brain Res; 2004 Jul; 1014(1-2):209-20. PubMed ID: 15213005
[TBL] [Abstract][Full Text] [Related]
16. Mice with Ppt1Deltaex4 mutation replicate the INCL phenotype and show an inflammation-associated loss of interneurons.
Jalanko A; Vesa J; Manninen T; von Schantz C; Minye H; Fabritius AL; Salonen T; Rapola J; Gentile M; Kopra O; Peltonen L
Neurobiol Dis; 2005 Feb; 18(1):226-41. PubMed ID: 15649713
[TBL] [Abstract][Full Text] [Related]
17. Selective spatiotemporal patterns of glial activation and neuron loss in the sensory thalamocortical pathways of neuronal ceroid lipofuscinosis 8 mice.
Kuronen M; Lehesjoki AE; Jalanko A; Cooper JD; Kopra O
Neurobiol Dis; 2012 Sep; 47(3):444-57. PubMed ID: 22569358
[TBL] [Abstract][Full Text] [Related]
18. Exacerbated neuronal ceroid lipofuscinosis phenotype in Cln1/5 double-knockout mice.
Blom T; Schmiedt ML; Wong AM; Kyttälä A; Soronen J; Jauhiainen M; Tyynelä J; Cooper JD; Jalanko A
Dis Model Mech; 2013 Mar; 6(2):342-57. PubMed ID: 23065637
[TBL] [Abstract][Full Text] [Related]
19. The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8.
Ranta S; Zhang Y; Ross B; Lonka L; Takkunen E; Messer A; Sharp J; Wheeler R; Kusumi K; Mole S; Liu W; Soares MB; Bonaldo MF; Hirvasniemi A; de la Chapelle A; Gilliam TC; Lehesjoki AE
Nat Genet; 1999 Oct; 23(2):233-6. PubMed ID: 10508524
[TBL] [Abstract][Full Text] [Related]
20. Deficient mitochondrial Ca(2+) buffering in the Cln8(mnd) mouse model of neuronal ceroid lipofuscinosis.
Kolikova J; Afzalov R; Surin A; Lehesjoki AE; Khiroug L
Cell Calcium; 2011 Dec; 50(6):491-501. PubMed ID: 21917311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
